Is F2 -isoprostane a biological marker for the early onset of type 2 diabetes mellitus?
Aim: This clinical study was undertaken to investigate whether F 2 -isoprostane, a prostaglandin F 2 -like compound derived from the non-enzymatic peroxidation of arachidonic acid, could serve as a novel biomarker for early detection of type 2 diabetes mellitus (T2DM) or its complications. Materials...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | View Fulltext in Publisher View in Scopus |